Theratechnologies announced the appointment of Elina Tea, CFO at GLS North America, to its Board of Directors and as a member of the Company’s Audit Committee. Ms. Tea will be Investissement Quebec’s designee pursuant to its investor rights agreement with the Company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THTX:
- Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update
- Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
- Theratechnologies Refocuses on Pioneering Ovarian Cancer Trial
- Theratechnologies Welcomes New Board Member
- Theratechnologies Refocuses on Commercial Growth
